Faulty Fat Sensor Implicated in Obesity and Liver Disease

20 Feb 2012 --- The researchers analysed the gene for GPR120 in 6,942 obese people and 7,654 controls to test whether differences in the code that carries instructions for making the protein contribute to obesity in humans.

Feb 20 2012 --- Defects in a protein that functions as a dietary fat sensor may be a cause of obesity and liver disease, according to a study published in the journal Nature, led by researchers at Imperial College London. The findings highlight a promising target for new drugs to treat obesity and metabolic disorders.

The protein GPR120 is found on the surface of cells in the gut, liver and fat tissue and allows cells to detect and respond to unsaturated fatty acids from the diet, especially the omega-3 fatty acids which are believed to have a beneficial impact on health. Scientists found that mice deficient in GPR120 were more prone to developing obesity and liver disease when fed a high-fat diet. They also found that people with a certain mutation in the gene encoding GPR120, which stops the protein from responding to omega-3 fatty acids, were significantly more likely to be obese.

In the gut, when unsaturated fatty acids from food bind to GPR120, this stimulates the release of hormones that suppress appetite and stimulate the pancreas to secrete insulin. When fat cells sense high levels of fat in the blood through GPR120, it stimulates them to divide to produce more fat cells to store all the fat, reducing the risk of fatty liver and furring of the arteries. This mechanism could be an important pathway for bringing about some of the healthy effects of omega-3s.

When they were fed on a high-fat diet, mice that lacked GPR120 not only became obese but also had fatty livers, lower numbers of fat cells, and poor control of blood glucose. The researchers believe that mice that are deficient in GPR120 have difficulty storing excess fat in fat tissue. Instead, their bodies store fat in areas where it can cause health problems, like the liver, the muscles and in the walls of arteries. In humans, this pattern of obesity is associated with type 2 diabetes and heart disease.

The study involved scientists in the UK, France and Japan. It was led by Professor Philippe Froguel, from the School of Public Health at Imperial College London.

"Being overweight is not always unhealthy if you can make more fat cells to store fat," said Professor Froguel. "Some people seem to be unable to do this, and instead they deposit fat around their internal organs, which is very unhealthy. Our study suggests that in both mice and humans, defects in GPR120 combined with a high-fat diet greatly increase the risk of this unhealthy pattern of obesity. We think GPR120 could be a useful target for new drugs to treat obesity and liver diseases."

The researchers analysed the gene for GPR120 in 6,942 obese people and 7,654 controls to test whether differences in the code that carries instructions for making the protein contribute to obesity in humans. They found that one mutation that renders the protein dysfunctional increases a person's risk of obesity by 60 per cent. The researchers think this mutation mimics the effect of a bad diet lacking in unsaturated omega-3 fat.

Related Articles

Health & Nutrition News

Diabetes UK: 75% of Britons Want Food Manufacturers to Cut Fat, Salt and Sugar From Their Products

05 Feb 2016 --- Three quarters of British adults want food manufacturers to reduce the amount of saturated fat, salt and added sugar in their products to make it easier for people to eat more healthily, according to a new survey from Diabetes UK. 
According to a ComRes survey commissioned by the charity, 69% of 18-24 year olds say they think food manufacturers should reduce the amount of saturated fat, added sugar and salt in their products and this number rises to 80% of people aged 65 and over. 

Regulatory News

EFSA Opens Public Consultation for Vitamin B6 Dietary Reference Values

05 Feb 2016 --- The European Food and Safety Authority (EFSA) has launched an open consultation on its draft scientific opinion on dietary reference values (DRVs) for vitamin B6. This document proposes recommendations for adults, infants and children, pregnant and lactating women.

Health & Nutrition News

Health Canada Approves Taiyo’s Sunfiber Health Claims for Treating IBS and Improving Childhood Constipation

04 Feb 2016 --- Taiyo’s branded ingredient Sunfiber has been granted two Health Claims in Canada: for treating symptoms of Irritable Bowel Syndrome (IBS) and for improving childhood constipation. US and European approvals may follow soon.
These approvals are supported by 29 types of published clinical studies.

Health & Nutrition News

Palm Gamma Tocotrienol Has Therapeutic Potential Against Type 2 Diabetes

02 Feb 2016 --- A new study published in the Journal of Lipid Research reveals that palm gamma-tocotrienol (γ-T3) retards inflammation in type 2 diabetes mouse models via inhibition of Nod-like receptor 3 (NLRP3) inflammasome (an intracellular sensor that detects imbalanced intake of nutrients such as excessive fats or glucose).

More Articles
URL : http://www.nutritioninsight.com:80/news/Faulty-Fat-Sensor-Implicated-in-Obesity-and-Liver-Disease.html